Welcome to CDC stacks | Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older - 26586 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Cervical cancer screening with the HPV test and the Pap test in women ages 30 and older
  • Published Date:
    9/4/12
  • Language:
    English
Filetype[PDF-1.28 MB]


Details:
  • Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.
  • Keywords:
  • Description:
    Information on cervical cancer screening for women ages 30 and older who have had the Pap and HPV tests.

    If you have had a Pap test and HPV test, this booklet will answer your questions about:

    • Cervical cancer

    • Human papillomavirus (HPV)

    • Cervical cancer screening tests

    • What your Pap test result means

    • What your HPV test result means

    • What your Pap and HPV test results mean together

    • How to prevent cervical cancer

    • Common questions about HPV

    • How to talk to your partner about your test results

    • Resources

    • Glossary of bolded words

    • Know the facts

    • Questions to ask your doctor

    Getting abnormal results does not mean that you have cervical cancer now. For specific questions about your test results, talk to your doctor.

  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Place as Subject:
    gau
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Trends of Human Papillomavirus Testing in Cervical Cancer Screening at a Large Academic Cytology Laboratory
    Personal Author:
    Phelan, Darcy F.; Boitnott, John K.; Clark, Douglas P.; Dubay, Lisa C.; Gravitt, Patti E.;
    Published:
    Aug 2011
    Source:
    Obstet Gynecol. 118(2 0 1):289-295.
    Description:
    OBJECTIVE : To estimate time trends of actual provider use of human papillomavirus (HPV) testing in cervical cancer screening by using laboratory and administrative data from the Johns Hopkins Hospital Division of Cytopathology in Baltimore, Maryland...
    File Type:
    Filetype[PDF - 702.84 KB]
  2. HPV Prevalence among Women from Appalachia: Results from the CARE Project
    Personal Author:
    Reiter, Paul L.; Katz, Mira L.; Ruffin, Mack T.; Hade, Erinn M.; DeGraffenreid, Cecilia R.; Patel, Divya A.; Paskett, Electra D.; Unger, Elizabeth R.;
    Published:
    Aug 30 2013
    Source:
    PLoS One. 2013; 8(8).
    Description:
    Background : Cervical cancer incidence and mortality rates are high among women from Appalachia, yet data do not exist on human papillomavirus (HPV) prevalence among these women. We examined the prevalence of genital HPV among Appalachian women and i...
    File Type:
    Filetype[PDF - 162.63 KB]
  3. Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers
    Personal Author:
    Roland, Katherine B.; Benard, Vicki B.; Greek, April; Hawkins, Nikki A.; Saraiya, Mona;
    Published:
    Aug 12 2014
    Source:
    Vaccine. 32(42):5432-5435.
    Description:
    Introduction : In the United States, Federally Qualified Health Centers (FQHCs) are safety-net clinics that provide cervical cancer screening and human papillomavirus (HPV) vaccination to medically underserved women, some of whom may be at risk for d...
    File Type:
    Filetype[PDF - 165.29 KB]
  4. Genital human papillomavirus (HPV)
    Corporate Author:
    Centers for Disease Control and Prevention; United States, Indian Health Service.; Centers for Disease Control and Prevention (U.S.);
    Published:
    2009
    Description:
    CDC-INFO Pub ID 999782
    File Type:
    Filetype[PDF - 1.24 MB]
  5. Evolution of cervical cancer screening and prevention in United States and Canada: Implications for public health practitioners and clinicians☆,☆☆
    Personal Author:
    Saraiya, M.; Steben, M.; Watson, M.; Markowitz, L.;
    Published:
    Feb 08 2013
    Source:
    Prev Med. 57(5):426-433.
    Description:
    Objective : Declines in cervical cancer incidence and mortality in Canada and in the United States have been widely attributed to the introduction of the Papanicolaou (Pap) test. This article reviews changes in screening and introduction of HPV vacci...
    File Type:
    Filetype[PDF - 1.27 MB]